Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

161
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
161
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

162
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
162
Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

278
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
278
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa01:22

Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

277
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
277
One-Compartment Open Model: Urinary Excretion Data and Determination of k01:11

One-Compartment Open Model: Urinary Excretion Data and Determination of k

290
The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also...
290
Determination of Renal Drug Clearance: Graphical and Midpoint Methods01:07

Determination of Renal Drug Clearance: Graphical and Midpoint Methods

203
Renal clearance, a crucial parameter in pharmacokinetics, can be determined using two different methods: the graphical method and the midpoint method. These methods provide insights into the rate of drug excretion by the kidneys and aid in assessing renal function.
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
203

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Evaluation of impact of clinical variables on enoxaparin dosing and anti-Xa factor concentration.

European journal of hospital pharmacy : science and practice·2025
Same author

Clopidogrel-induced thrombotic microangiopathy: a case report.

European journal of hospital pharmacy : science and practice·2024
Same author

Benznidazole-induced drug reaction with eosinophilia and systemic symptoms syndrome in a patient with human leucocyte antigen (HLA)-A*68.

European journal of hospital pharmacy : science and practice·2024
Same author

Predictive performance of glomerular filtration rate equations based on cystatin C, creatinine and their combination in critically ill patients.

European journal of hospital pharmacy : science and practice·2023
Same author

Stability of 5% vancomycin ophthalmic solution prepared using balanced salt solution after freezing for 90 days.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2021
Same author

Dose banding of intravenous ganciclovir: Banding scheme proposal and audit of toxicity and efficiency.

Journal of clinical pharmacy and therapeutics·2021

相关实验视频

Updated: Sep 14, 2025

Physiology Lab Demonstration: Glomerular Filtration Rate in a Rat
06:58

Physiology Lab Demonstration: Glomerular Filtration Rate in a Rat

Published on: July 26, 2015

17.5K

使用不同的功能估计方程对万科米辛剂量的影响.

Laura Gratacós1, Dolors Soy-Muner2

  • 1Pharmacy, Hospital Universitario de Girona Doctor Josep Trueta, Girona, Spain lgratacos.girona.ics@gencat.cat.

European journal of hospital pharmacy : science and practice
|July 18, 2025
PubMed
概括
此摘要是机器生成的。

考克克罗夫特-高尔特 (CG) 公式最好地预测了万科米辛的最低度 (Cmin). 功能估计方程在优化万科米辛剂量方面是不可互换的.

关键词:
药物监测 药物监测 药物监测功能衰竭,慢性功能衰竭药剂师们 药剂师们药物动力学 药物动力学药房服务,医院服务.

更多相关视频

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

23.8K
A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.6K

相关实验视频

Last Updated: Sep 14, 2025

Physiology Lab Demonstration: Glomerular Filtration Rate in a Rat
06:58

Physiology Lab Demonstration: Glomerular Filtration Rate in a Rat

Published on: July 26, 2015

17.5K
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

23.8K
A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.6K

科学领域:

  • 药理动力学和药理动力学
  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 传染性疾病 传染性疾病

背景情况:

  • 精确估计功能对于优化万科米辛剂量至关重要.
  • 为了估计功能,存在多种公式,包括Cockcroft-Gault (CG),CKD-EPI和MDRD.
  • 这些配方的可互换性,用于范胺剂量调整,需要进一步研究.

研究的目的:

  • 为了比较CG,CKD-EPI和MDRD公式在预测万科米辛最小度 (Cmin) 中的准确性.
  • 为了确定这些配方是否可以互换地用于万科米辛剂量优化.

主要方法:

  • 对接受静脉注射万科米辛的住院成年患者进行了观察性回顾性研究.
  • 排除标准包括严重的功能障碍,高的BMI,体外清除和不稳定的功能.
  • 贝叶斯分析被用来获得个别的药理学参数,包括通过CG,CKD-EPI和MDRD公式估计的米素清除率 (CLvan).
  • 估计的Cmin (eCmin) 与观察到的Cmin使用课内相关系数 (ICC) 和卡帕系数对曲线下面面积 (AUC) 的一致性进行比较.

主要成果:

  • 在大多数子组中,CG公式显示了与观察到的Cmin (ICC>0.7) 的统计学上显著更好的一致性.
  • 只有在血清肌素 (Scr) >1.1 mg/dL的患者中,MDRD和CKD-EPI与CG显示出足够的一致性.
  • 在各个子组之间达成的协议有所不同,CG在低体重和老年患者中显示出优异的Cmin预测.

结论:

  • 考克克罗夫特-高尔特 (CG) 公式是最准确的预测万科米辛Cmin.
  • 在特定的亚组中,MDRD公式显示出良好的预测能力 (eGFR <60 mL/min,年龄46-75岁).
  • 功能估计公式在优化万科米辛剂量方面是不可互换的,这凸显了根据患者特征选择合适配方的重要性.